White House’s Covid coordinator urges people to get vaccinated ahead of holidays

White House’s Covid coordinator urges people to get vaccinated ahead of holidays


White House COVID-19 Response Coordinator Ashish Jha at the White House in Washington, October 25, 2022.

Jonathan Ernst | Reuters

As Covid and flu hospitalizations have climbed in the weeks since Thanksgiving, White House’s Covid-19 coordinator Dr. Ashish Jha said families will be safer at upcoming holiday gatherings if they get their updated vaccines.

This year, hospitals are facing the simultaneous threat of Covid, flu and RSV for the first time. Circulation of flu and RSV was very low during the pandemic due to widespread masking and social distancing implemented in response to Covid, but as most people return to normal life, all three viruses are circulating widely.

As of Dec. 14, the 7-day average of weekly new Covid cases reached 65,067, a 2.9% decrease from the previous week, according to CDC data.

“The good news here is that we can prevent those infections from turning into serious illness if people go out and get that updated bivalent vaccine,” Jha told ABC’s “This Week” Sunday.

Public health officials have said many people are probably more vulnerable to flu and RSV this year because they weren’t infected in the past two years, which means their immunity is lower. Around 23,503 patients were admitted to the hospital with influenza this week, the CDC reported, while RSV hospitalizations appear to have peaked in some states.

Hospitalizations of people with Covid topped more than 5,000 per day on average, according to the CDC.

“The updated vaccine is essential for keeping people out of the hospital,” Jha said. “So we’re making the case that we’re at a point where it’s safe to gather, but you still have things to do.”



Source

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say
Health

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

The growth of China’s biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and helping launch a new wave of labs and incubators in the country. That’s a problem for the U.S. biotech industry and also affects rare disease patients who are waiting for a cure. Among the experts […]

Read More
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
Health

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good morning from San Francisco! It’s day three of the annual JPMorgan Healthcare Conference – the biggest gathering of biotech and pharma execs, investors and analysts in […]

Read More
OpenAI acquires health-care technology startup Torch
Health

OpenAI acquires health-care technology startup Torch

OpenAI has acquired the health-care technology startup Torch, the company announced on Monday. Torch was building a “unified medical memory” for artificial intelligence that aimed to bring a patient’s health data, which is typically siloed and stored across a number of different vendors and formats, into one place. Torch’s employees will join OpenAI as part […]

Read More